Article
What rheumatologists need to know about CRISPR/Cas9.
Nature reviews. Rheumatology - 1 Apr 2017
Gibson Gary J, Yang Maozhou
Abstract excerpt
CRISPR/Cas9 genome editing technology has taken the research world by storm since its use in eukaryotes was first proposed in 2012. Publications describing advances in technology and new applications have continued at an unrelenting pace since that time. In this Review, we discuss the application of CRISPR/Cas9 for creating gene mutations - the application that initiated the current avalanche of interest - and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
